Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals (AMLX)

29.72 +0.69 (2.38%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

U.S. biotech SMids: Q3 earnings preview October 18, 2026 8:00 PM - StreetInsider Form 4 Amylyx Pharmaceuticals, For: Oct 05 Filed by: MILNE GEORGE M JR October 7, 2026 4:00 PM - SEC Filing Amylyx to present Phase 3 avexitide trial data at ObesityWeek 2026 October 6, 2026 8:01 AM - StreetInsider Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting October 6, 2026 8:00 AM - BizWire Form 144 Amylyx Pharmaceuticals, Filed by: MILNE GEORGE M JR October 5, 2026 4:38 PM - SEC Filing Amylyx Pharmaceuticals (AMLX) Reiterated at Buy by Stifel on Ph3 Data for Avexitide October 1, 2026 7:24 AM - StreetInsider Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum September 23, 2026 9:00 AM - BizWire Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Bedrosian Camille L September 14, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: FRATES JAMES M September 14, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Klee Justin B. September 14, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Mazzariello Gina September 14, 2026 4:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Cohen Joshua B September 14, 2026 4:00 PM - SEC Filing Form 144 Amylyx Pharmaceuticals, Filed by: Cohen Joshua B September 11, 2026 4:01 PM - SEC Filing Form 144 Amylyx Pharmaceuticals, Filed by: Klee Justin B. September 11, 2026 4:01 PM - SEC Filing Form 144 Amylyx Pharmaceuticals, Filed by: Bedrosian Camille L September 11, 2026 4:01 PM - SEC Filing Form 144 Amylyx Pharmaceuticals, Filed by: Mazzariello Gina September 11, 2026 4:01 PM - SEC Filing Form 144 Amylyx Pharmaceuticals, Filed by: FRATES JAMES M September 11, 2026 4:01 PM - SEC Filing Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $57 at Guggenheim August 27, 2026 6:55 AM - StreetInsider Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Klee Justin B. August 20, 2026 9:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: FRATES JAMES M August 20, 2026 9:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Mazzariello Gina August 20, 2026 9:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Cohen Joshua B August 20, 2026 9:00 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Bedrosian Camille L August 20, 2026 9:00 PM - SEC Filing Form 8-K Amylyx Pharmaceuticals, For: Aug 19 August 20, 2026 5:28 PM - SEC Filing Form 424B5 Amylyx Pharmaceuticals, August 20, 2026 5:28 PM - SEC Filing Amylyx prices $500M stock offering at $35.50 per share August 19, 2026 11:06 PM - StreetInsider Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock August 19, 2026 11:06 PM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim August 19, 2026 7:26 AM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $52 at Baird August 19, 2026 6:37 AM - StreetInsider Form 424B5 Amylyx Pharmaceuticals, August 18, 2026 5:18 PM - SEC Filing Amylyx Pharmaceuticals launches $350M common stock offering August 18, 2026 4:01 PM - StreetInsider Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock August 18, 2026 4:01 PM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho August 18, 2026 3:40 PM - StreetInsider Amylyx Pharmaceuticals (AMLX) 19K contracts trade August 18, 2026 1:51 PM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright August 18, 2026 12:28 PM - StreetInsider Form 8-K Amylyx Pharmaceuticals, For: Aug 18 August 18, 2026 9:04 AM - SEC Filing Form 8-K Amylyx Pharmaceuticals, For: Aug 18 August 18, 2026 7:10 AM - SEC Filing Amylyx's avexitide cuts hypoglycemia events 55% in Phase 3 trial August 18, 2026 7:00 AM - StreetInsider Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia August 18, 2026 7:00 AM - BizWire Amylyx to release Phase 3 avexitide trial results Aug. 18 August 17, 2026 4:01 PM - StreetInsider Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026 August 17, 2026 4:01 PM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $30 at Mizuho August 17, 2026 6:38 AM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $28 at Baird August 6, 2026 3:50 PM - StreetInsider Form 10-Q Amylyx Pharmaceuticals, For: Jun 30 August 6, 2026 7:04 AM - SEC Filing Form 8-K Amylyx Pharmaceuticals, For: Aug 06 August 6, 2026 7:02 AM - SEC Filing Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q2 EPS by 4c August 6, 2026 7:01 AM - StreetInsider Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results August 6, 2026 7:00 AM - BizWire Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026 August 3, 2026 9:00 AM - BizWire Full Article List